140 related articles for article (PubMed ID: 9803400)
1. Functional and metabolic evaluation of the hypertrophied heart using MRI and 31P-MRS.
Lamb HJ; van der Laarse A; Pluim BM; Beyerbacht HP; Doornbos J; van der Wall EE; de Roos A
MAGMA; 1998 Sep; 6(2-3):168-70. PubMed ID: 9803400
[No Abstract] [Full Text] [Related]
2. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
[TBL] [Abstract][Full Text] [Related]
3. Myocardial perfusion and oxygenation are impaired during stress in severe aortic stenosis and correlate with impaired energetics and subclinical left ventricular dysfunction.
Mahmod M; Francis JM; Pal N; Lewis A; Dass S; De Silva R; Petrou M; Sayeed R; Westaby S; Robson MD; Ashrafian H; Neubauer S; Karamitsos TD
J Cardiovasc Magn Reson; 2014 Apr; 16(1):29. PubMed ID: 24779370
[TBL] [Abstract][Full Text] [Related]
4. Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium.
Neubauer S; Beer M; Landschütz W; Sandstede J; Seyfarth T; Lipke C; Köstler H; Pabst TKenn W; Meininger M; von Kienlin M; Horn M; Harre K; Hahn D
MAGMA; 2000 Nov; 11(1-2):73-4. PubMed ID: 11186995
[No Abstract] [Full Text] [Related]
5. Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy.
Pluim BM; Lamb HJ; Kayser HW; Leujes F; Beyerbacht HP; Zwinderman AH; van der Laarse A; Vliegen HW; de Roos A; van der Wall EE
Circulation; 1998 Feb; 97(7):666-72. PubMed ID: 9495302
[TBL] [Abstract][Full Text] [Related]
6. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
Neubauer S; Horn M; Pabst T; Harre K; Strömer H; Bertsch G; Sandstede J; Ertl G; Hahn D; Kochsiek K
J Investig Med; 1997 Oct; 45(8):453-62. PubMed ID: 9394098
[TBL] [Abstract][Full Text] [Related]
7. [31P Magnetic Resonance Spectroscopy in Patients With Various Genesis of Left Ventricular Hypertrophy].
Ternovoy SK; Mazaev VV; Stukalova OV; Serova NS
Kardiologiia; 2015; 55(9):5-9. PubMed ID: 26898088
[TBL] [Abstract][Full Text] [Related]
8. Functional and metabolic consequences of aortic valve replacement.
Lamb HJ
MAGMA; 2000 Nov; 11(1-2):75-7. PubMed ID: 11186996
[No Abstract] [Full Text] [Related]
9. [Postoperative follow-up results of aortic valve diseases--the relationship between residual left ventricular hypertrophy and dysfunctions of contractile and dilative functions].
Taniguchi K; Mitsuno M; Imagawa H; Shimazaki Y; Nakano S; Matsuda A
Nihon Kyobu Geka Gakkai Zasshi; 1996 Mar; 44(3):324-6. PubMed ID: 8926406
[No Abstract] [Full Text] [Related]
10. High-energy phosphate responses to tachycardia and inotropic stimulation in left ventricular hypertrophy.
Bache RJ; Zhang J; Path G; Merkle H; Hendrich K; From AH; Ugurbil K
Am J Physiol; 1994 May; 266(5 Pt 2):H1959-70. PubMed ID: 8203595
[TBL] [Abstract][Full Text] [Related]
11. Aortic valve replacement in patients with aortic valve stenosis improves myocardial metabolism and diastolic function.
Beyerbacht HP; Lamb HJ; van Der Laarse A; Vliegen HW; Leujes F; Hazekamp MG; de Roos A; van Der Wall EE
Radiology; 2001 Jun; 219(3):637-43. PubMed ID: 11376247
[TBL] [Abstract][Full Text] [Related]
12. Concentration of human cardiac 31P-metabolites determined by SLOOP 31P-MRS.
Landschütz W; Meininger M; Beer M; Seyfarth T; Horn M; Pabst T; Haase A; Hahn D; Neubauer S; von Kienlin M
MAGMA; 1998 Sep; 6(2-3):155-6. PubMed ID: 9803396
[No Abstract] [Full Text] [Related]
13. Bioenergetic abnormalities associated with severe left ventricular hypertrophy.
Zhang J; Merkle H; Hendrich K; Garwood M; From AH; Ugurbil K; Bache RJ
J Clin Invest; 1993 Aug; 92(2):993-1003. PubMed ID: 8349829
[TBL] [Abstract][Full Text] [Related]
14. Role of Cardiac Energetics in Aortic Stenosis Disease Progression: Identifying the High-risk Metabolic Phenotype.
Monga S; Valkovič L; Myerson SG; Neubauer S; Mahmod M; Rider OJ
Circ Cardiovasc Imaging; 2023 Oct; 16(10):e014863. PubMed ID: 37847766
[TBL] [Abstract][Full Text] [Related]
15. Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake. A 31P NMR spectroscopic study.
Zhang J; Duncker DJ; Ya X; Zhang Y; Pavek T; Wei H; Merkle H; Uğurbil K; From AH; Bache RJ
Circulation; 1995 Sep; 92(5):1274-83. PubMed ID: 7648676
[TBL] [Abstract][Full Text] [Related]
16. [Cardiac metabolism in aortic valve diseases].
Mezzetti A; Cuccurullo F; Oldani A; Masi M; Rosini R; Tomasetti V; Begliomini B; Palmeggiani G; Lenzi S
Boll Soc Ital Cardiol; 1977; 22(11):2113-22. PubMed ID: 224893
[No Abstract] [Full Text] [Related]
17. Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction.
McDonald KM; Yoshiyama M; Francis GS; Ugurbil K; Cohn JN; Zhang J
J Am Coll Cardiol; 1994 Mar; 23(3):786-93. PubMed ID: 8113565
[TBL] [Abstract][Full Text] [Related]
18. Detection of monoester signals in human myocardium by 31P-MRS.
Widmaier S; Jung WI; Sieverding L; Breuer J; Schmidt O; Dietze GJ; Lutz O
MAGMA; 1998 Sep; 6(2-3):161-3. PubMed ID: 9803398
[No Abstract] [Full Text] [Related]
19. Normalization of left ventricular dimensions after Ross operation with aortic annular reduction.
Niwaya K; Elkins RC; Knott-Craig CJ; Santangelo KL; Cannon MB; Lane MM
Ann Thorac Surg; 1999 Sep; 68(3):812-8; discussion 818-9. PubMed ID: 10509967
[TBL] [Abstract][Full Text] [Related]
20. The relationship of left ventricular geometry and hypertrophy to left ventricular function in valvular heart disease.
Carabello BA
J Heart Valve Dis; 1995 Oct; 4 Suppl 2():S132-8; discussion S138-9. PubMed ID: 8563989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
